Leptomycin B

Leptomycin B Struktur
87081-35-4
CAS-Nr.
87081-35-4
Englisch Name:
Leptomycin B
Synonyma:
Lepomycin B;Leprimycin B;antibioticci940;antibioticcl1957a;Leptomycin B solutio;Leptomycin B (CI 940;LeptoMycin B 1% soluton;Leptomycin B (0.2mg/ml);InSolution? Leptomycin B,;LeptoMycin B( CI 940, LMB)
CBNumber:
CB9500811
Summenformel:
C33H48O6
Molgewicht:
540.73
MOL-Datei:
87081-35-4.mol

Leptomycin B Eigenschaften

Schmelzpunkt:
41-44°, with prior softening (Hokanson)
alpha 
D -24.5° (c = 0.70 in MeOH); D23 -157 ° (c = 0.7% in chloroform)
Siedepunkt:
725.8±60.0 °C(Predicted)
Dichte
1.072±0.06 g/cm3(Predicted)
Flammpunkt:
11°(52°F)
storage temp. 
−20°C
Löslichkeit
Supplied in solution in ethanol (1 mg/ml). Further dilutions may be made with either ethanol or DMSO.
Aggregatzustand
Liquid
pka
5.10±0.33(Predicted)
Farbe
White to off-white
Stabilität:
Stable for 1 year from date of purchase as supplied. Solutions or dilutions in DMSO are not stable. Solutions should be made fresh and used within one working day.
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher F,T
R-Sätze: 23/25-36/38-39/23/24/25-23/24/25-11
S-Sätze: 7-16-24-33-45-36/37
RIDADR  UN 1230 3/PG 2
WGK Germany  3
HazardClass  3
HS Code  29419090
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H225 Flüssigkeit und Dampf leicht entzündbar. Entzündbare Flüssigkeiten Kategorie 2 Achtung GHS hazard pictogramssrc="/GHS02.jpg" width="20" height="20" /> P210,P233, P240, P241, P242, P243,P280, P303+ P361+P353, P370+P378,P403+P235, P501
H370 Schädigt die Organe. Spezifische Zielorgan-Toxizität (einmalige Exposition) Kategorie 1 Achtung GHS hazard pictogramssrc="/GHS08.jpg" width="20" height="20" /> P260, P264, P270, P307+P311, P321,P405, P501
Sicherheit
P210 Von Hitze, heißen Oberflächen, Funken, offenen Flammen und anderen Zündquellenarten fernhalten. Nicht rauchen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.

Leptomycin B Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R23/25:Giftig beim Einatmen und Verschlucken.
R36/38:Reizt die Augen und die Haut.

S-Sätze Betriebsanweisung:

S7:Behälter dicht geschlossen halten.
S16:Von Zündquellen fernhalten - Nicht rauchen.
S24:Berührung mit der Haut vermeiden.
S33:Maßnahmen gegen elektrostatische Aufladungen treffen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).

Verwenden

Leptomycin B is the dominant and most studied member of the leptomycin class, isolated from selected Streptomyces strains. Leptomycin B is a nanomolar active and specific nuclear export inhibitor. Its target is CRM1/exportin1, a protein in the nuclear export sequence (NES). Proteins affected include c-Abl, cyclin B1, HIV-1 Rev, IκB, MPF, MAP/ERK, MDM2/p53, NF-κB/IκB7 and PKA. Leptomycin B inhibits export of many RNAs, e.g. COX-2 and c-FOS mRNA. Leptomycin B also shows antifungal and antibacterial and potent antitumour activities.

Definition

ChEBI: A leptomycin having a (2E,10E,12E,16Z,18E)-double bond configuration as well as an ethyl substituent at position 17.

Allgemeine Beschreibung

Leptomycin B is an anti-fungal antibiotic, anti-tumor cytotoxin that inhibits CRM1-dependent, NES-dependent nucleo-cytoplasmic translocation (nuclear export inhibitor). NES containing proteins include HIV-1 REV; actin, c-Abl, cyclin B1, MDM2/p53, I?B, MPF, PKA and MEK.

Biologische Aktivität

Antifungal antibiotic that is an inhibitor of the nuclear export of proteins; acts by binding directly to and inhibiting CRM1/exportin-1. Inhibits the nuclear export of the HIV regulatory protein Rev and stabilizes p53. Antitumor in vitro and in vivo .

Mechanism of action

The nuclear export inhibition mechanism involves the direct binding of Leptomycin B to exportin1, which blocks the binding of exportin1 to proteins containing the leucine-rich NES. Later, NES-exportin1 interaction was identified on a conserved region near cysteine-529 residue of human exportin1. This cysteine-529 residue on exportin1 provides LMB sensitivity because unsaturated γ-lactone in LMB undergoes a Michael-type reaction by the sulfhydryl group on cysteine residue. Once LMB is bound to exportin1, the NES-bearing nuclear export cargo fails to bind the receptor.

Leptomycin B Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Leptomycin B Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 130)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shanghai Minbiotech Co., Ltd.
+8617315815539
sales@minbiotech.com CHINA 129 58
Fuxin Pharmaceutical
+86-021-021-50872116 +8613122107989
contact@fuxinpharm.com China 10297 58
career henan chemical co
+86-0371-86658258 15093356674;
factory@coreychem.com China 29826 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-81138252 +86-18789408387
1057@dideu.com China 3586 58
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
+86-021-61551413 +8618813727289
contact@trustwe.com China 5738 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Hubei Ipure Biology Co., Ltd
+8613367258412
ada@ipurechemical.com China 10326 58
Zhejiang Huida Biotech Co., LTD
008613515763466 8615669048680
wendy@huidabiotech.com CHINA 87 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9358 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250
1026@dideu.com China 29271 58

87081-35-4()Verwandte Suche:


  • (2E,10Z,12E,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-(3-methyl-6-oxo-2,3-dihydropyran-2-yl)-8-oxo-nonadeca-2,10,12,16,18-pentaenoic acid
  • 2,10,12,16,18-Nonadecapentaenoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-
  • 2,10,12,16,18-Nonadecapentanoic acid, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-
  • (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-19-[(2S,3S)-3,6-Dihydro-3-methyl-6-oxo-2H-pyran-2-yl]-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-2,10,12,16,18-nonadecapentaenoicacid
  • LeptoMycin B( CI 940, LMB)
  • antibioticcl1957a
  • CI-940, Elactocin, PD 114720, ATS 1287B, Mantuamycin, 19-(3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-2,10,12,16,18-Nonadecapentaenoic acid
  • Elactocin, ATS 1287B, CI 940, CL 1957A, PD 114720, MantuaMycin
  • 2,10,12,16,18-Nonadecapentaenoicacid,19-[(2S,3S)-3,6-dihydro-3-methyl-6-oxo-2H-pyran-2-yl]-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-8-oxo-,(2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-
  • NSC 364372 CL 1957A Leptomycin B Antibiotic CI 940 Antibiotic CL 1957A
  • Leptomycin B solution from Streptomyces sp.
  • InSolution? Leptomycin B,
  • LeptoMycin B 1% soluton
  • LEPTOMYCIN B FROM STREPTOMYCES SP
  • 2,10,12,16,18-nonadecapentanoicacid,19-(3,6-dihydro-3-methyl-6-oxo-2h-pyran-2
  • 7,9,11,15-hexamethyl-8-oxo--yl)-17-ethyl-6-hydroxy-5
  • antibioticci940
  • Leptomycin B (CI 940
  • InSolution Leptomycin B, Streptomyces sp. - CAS 87081-35-4 - Calbiochem
  • Leptomycin B (0.2mg/ml)
  • Leptomycin B (5 μg/mL in Ethanol)
  • Leptomycin B solutio
  • LEPTOMYCIN B FROM STREPTOMYCES SP USP/EP/BP
  • XPO1,Chromosomal Maintenance 1,Fungal,inhibit,CI-940,EMT,Antibiotic,Leptomycin B,p53,nuclear export,mutation,EGFR,NSCLC,resistance,Inhibitor,CRM1,CI940,cancer,Exportin 1,KRAS
  • Lepomycin B
  • Leprimycin B
  • 87081-35-4
  • C33H48O6
  • antibiotic
  • Antifungal
Copyright 2019 © ChemicalBook. All rights reserved